Mizu - Dein Begleiter bei CKD
26
Quality Score
Niche
Mizu - Dein Begleiter bei CKD
Low confidence
✍️ bumetric analysis
“
Mizu - Dein Begleiter bei CKD is an iOS app from Carealytix Digital Health GmbH in the Education category, currently rated 2.3★ across 3 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 26: Niche (micro-niche or pre-traction stage). For a Education app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$200
per month
→
12-mo forecast
$100 – $931
per month
→
24-mo forecast
$100 – $2790
per month
MICRO tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
ONE-TIME · BUILD
💰 Estimated build cost
$100K
↳ What it cost to build · not monthly revenue
Likely range $75K – $135K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 📦 Asset bundle (134 MB) | +$33K |
| ⚙ Education complexity ×1.20 | +$16K |
Total estimate
$100K
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$200/mo · ML-estimated from 234 triggers
Growth rate
+8.0% MoM · MICRO tier baseline (compound monthly)
Direction
Headwinds: rating drift may slow acquisition
6 months
$127 – $508
12 months
$100 – $931
24 months
$100 – $2.8K
Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Insufficient data · 31/100MICRO TIERtoo early to scoreRevenue Strength
2.3
Product Quality
1.9
Market Position
0.0
Growth Velocity
5.0
Defensibility
3.4
Operational Safety
8.0
Founder Strength
2.9
Monetization Maturity
1.0
- 💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
- ⭐ Quality: 2.33★ across 3 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $3K-$6K.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 5 of 5 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Below-average rating (2.3★)METRIC | −$1,500 | |
| Established app (5y old)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Localized (5 languages)METRIC | +$600 | |
| Pre-traction phase (3 ratings)METRIC | −$300 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Mizu - Dein Begleiter bei CKD
- Developer
- Carealytix Digital Health GmbH
- Bundle ID
- com.Carealytix.MikuApp
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 12+
- Languages
- EN, FR, DE, IT, ES
Company
- Website
- Not found
- Tagline
- Mizu: Dein Begleiter im Leben mit Nierenkrankheit
- Description
- Hol' dir die App gratis - Mehr als 8,000 Nutzer vertrauen bereits in Mizu - Erstdiagnose CKD, CKD 3-4, Dialyse, Nierentransplantation - Ärztlich validierte Funktionen & Inhalte - Ernährungstagebuch, Logbuch, Medikation, Reisen & Co.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $86/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
- Socials
- instagram instagram.com/mizu.ckd · twitter carealytix.com/careers · youtube youtube.com/@MizuApp
- info@mizu-app.com
- Phone
- Not found
- Contact page
- Not found
- About page
- Not found
📈Ratings growth3 ratings+200% lifetimeShow 3-year history estimate ▾
Tracked (4 weeks) Pre-tracking estimate (37 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
Mizu helps you manage your chronic kidney disease (CKD) with a vital parameters logbook, kidney-specific food diary, medication tracking, educational resources and travel dialysis finder.
You can use the app in early-stage of CKD, undergoing regular dialysis treatment as well as living with a functioning kidney transplant.
Mizu was developed in close collaboration with leading nephrologists, university hospitals, patients and caregivers. We have ongoing partnerships with several patient associations and support networks, as well as medical research institutions.… View full description on the official store →
You can use the app in early-stage of CKD, undergoing regular dialysis treatment as well as living with a functioning kidney transplant.
Mizu was developed in close collaboration with leading nephrologists, university hospitals, patients and caregivers. We have ongoing partnerships with several patient associations and support networks, as well as medical research institutions.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →💾 134 MB🔞 12+📱 iOS 15.1+🔖 v3.15.1🔄 updated 0d ago🌐 EN, FR, DE, IT, ES📂 Education💰 Paid
📅
What Worked™ · Development Pipeline
6 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
⭐
Rating ↓ 3.80 → 2.33 (dropped 1.47★)
2026-05
🔄
Monetization changed: freemium → free
2026-03
⭐
Rating ↑ 3.00 → 3.80 (improved 0.80★)
2026-03
📈
Crossed 10 ratings — social-proof flywheel kicking in
2026-01
⭐
Rating ↓ 5.00 → 3.00 (dropped 2.00★)
2022-09
🚀
First tracked snapshot — initial data captured
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
About this analysis
Why low confidence: only 3 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
📌 Final verdict — read this before you trust the numbers above
Mizu - Dein Begleiter bei CKD is a very early-stage iOS app in the education space with weak public traction — only 3 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Mizu - Dein Begleiter bei CKD make per month?▴
Low-confidence model estimate. Mizu - Dein Begleiter bei CKD has only 3 App Store ratings, so our revenue model has very little signal to work with — treat the ~$86/mo figure as directional only, not a verified MRR. No founder-verified revenue data is available for this app. See methodology for the formula and confidence bands.
What apps are like Mizu - Dein Begleiter bei CKD?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Mizu - Dein Begleiter bei CKD?▴
Mizu - Dein Begleiter bei CKD is published by Carealytix Digital Health GmbH on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Mizu - Dein Begleiter bei CKD's BU Score?▴
Mizu - Dein Begleiter bei CKD has a BU Score of 26/100 (Niche). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.